📈 Live Market Tracking

Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.

Live Latest filing: 2026-10-05 13:20 23 analysed today
FollowTelegram
23
Today
154,304
All-time analysed
44,412
Positive
6,863
Negative
94,026
Neutral
8,935
Watch
Note: These are AI-generated, educational summaries of public NSE filings — grounded in each document, but not investment advice and possibly incomplete. Verify against the original filing and consult a SEBI-registered adviser before acting.
Clear
101 announcements match Impact 5+ Symbol: LAL
NEUTRAL Impact 6/10 ROUTINE

Vadilal Seeks EGM Nod for ₹1,426 Cr 12-Month Related Party Supply Pact with VEL

Vadilal Industries Limited has issued an EGM notice for October 27, 2026, seeking shareholder approval for a 12-month supply agreement with related party Vadilal Enterprises Limited (VEL). The agreement covers the supply of ice creams and frozen food for an aggregate amount not exceeding ₹1,426 crore from November 1, 2026, to October 31, 2027. This replaces the previous 10-year distribution agreement entered in September 2016 which is expiring. Notably, the transaction value represents ~85% of Vadilal Industries' TTM revenue of ₹1,675 crore, serving as a critical short-term continuity measure pending alternative distribution plans.

NEUTRAL Impact 5/10 M&A

Dr. Lal PathLabs Completes Acquisition of Stake in SN Genelab

Dr. Lal PathLabs Ltd. has completed its acquisition of a stake in SN Genelab Private Limited on October 01, 2026. This follows the board approval previously intimated on September 24, 2026. Detailed financial consideration and exact stake percentages were disclosed in the earlier filing and not reiterated in this notice. The transaction aligns with the company's stated strategy to deepen specialized testing capabilities.

NEUTRAL Impact 5/10 OTHER

Goyal Aluminiums Shareholders Approve Divestment in Associate Wroley E India and ₹100 Cr Transactions

Goyal Aluminiums Limited reported the voting results of its 10th AGM held on September 30, 2026. Shareholders approved all 7 resolutions, including the divestment of its investment in associate Wroley E India Private Limited with 99.97% votes in favour. Additionally, shareholders approved material related-party transactions of up to ₹100 crore (97.16% in favour), which is significant against the company's TTM revenue of ₹77 crore. Regularisation of two independent directors and financial statements for FY26 were also passed.

WATCH Impact 6/10 OTHER

Vadilal Industries Approves 12-Month Revised Supply Agreement with Vadilal Enterprises

Vadilal Industries Limited has reached an agreement with Vadilal Enterprises Limited (VEL) to execute a revised supply agreement for a 12-month period from November 1, 2026, to October 31, 2027. This follows the scheduled expiration of their 10-year agreement on September 30, 2026, which VEL's public shareholders previously failed to renew. The revised agreement has been approved by the Audit Committee and Board on September 30, 2026, but remains conditional upon shareholder approvals from both companies.

Motilal Oswal Financial Services Allots ₹900 Cr NCDs at 8.64% Coupon

Motilal Oswal Financial Services Limited has approved the allotment of 90,000 senior, rated, secured, redeemable Non-Convertible Debentures (NCDs) aggregating to ₹900 crore via private placement. The issue was fully subscribed at a premium of ₹63 lakh, carrying an effective coupon rate of 8.64% per annum. The instruments have a tenure of 3 years and 25 days, maturing on October 25, 2029, and will be listed on the NSE. The debt raised represents approximately 6.55% of the company's existing debt of ₹13,732 crore.

📊 Last 7 days — analysed filings by sentiment

positivenegativeneutralwatch
POSITIVE Impact 6/10 M&A

Dr Lal PathLabs Completes Acquisition of 80% Stake in Ghana-Based Sunshine Healthcare

Dr. Lal Path Labs Ltd. announced that its wholly owned subsidiary, Dr Lal PathLabs FZCO (Dubai), has completed the acquisition of an 80% stake in Sunshine Healthcare Limited (SHL), Ghana. This follows the prior board approval intimated on July 24, 2026, making SHL a step-down subsidiary. Deal consideration and financial figures for SHL were not disclosed in this filing. The move aligns with the company's selective international footprint expansion into African markets.

POSITIVE Impact 7/10 M&A

Dr. Lal PathLabs to Acquire 70% Stake in SN Genelab for Up to ₹199.5 Cr

Dr. Lal PathLabs has approved the acquisition of a 70% stake in Gujarat-based SN Genelab Private Limited for a cash consideration of up to ₹168 crore, plus performance-linked earn-outs capped at ₹31.5 crore. SN Genelab specializes in diagnostics genomics and reported a turnover of ₹57.96 crore in FY26 (~2% of Dr. Lal's TTM revenue of ₹2,892 crore). The acquisition aims to strengthen the company's genomics capabilities and is scheduled for completion by November 30, 2026. Post-acquisition, SN Genelab will operate as a subsidiary.

Motilal Oswal to Raise up to ₹900 Cr via Secured NCDs on Private Placement

Motilal Oswal Financial Services has approved the issuance of up to 90,000 senior, rated, secured NCDs of face value ₹1,00,000 each, aggregating up to ₹900 crore on a private placement basis. The issue size represents approximately 6.5% of its total debt of ₹13,732 crore and 1.4% of its market capitalization. The debentures carry a tenure of 3 years and 26 days and are backed by a minimum 1.00x first-ranking pari passu charge on company receivables. The proceeds support its balance sheet operations, including lending and treasury investments.

Motilal Oswal Secures SEBI Custodian License to Complete Institutional Offerings

Motilal Oswal Financial Services Limited announced that its wholly-owned subsidiary, Motilal Oswal Custodial Services Private Limited (MOCSPL), received SEBI approval on September 23, 2026, to act as a Custodian of Securities. This enables the group to offer safekeeping, trade settlement, and post-trade services to institutional clients such as AIFs, PMS, mutual funds, and pension funds. Operations are targeted to commence in the last quarter of 2026, subject to operational readiness. This license completes the firm's end-to-end institutional services value chain alongside broking and asset management.

WATCH Impact 9/10 REGULATORY

India Ratings Places Vadilal Industries Bank Facilities on Rating Watch with Negative Implications

India Ratings and Research (Ind-Ra) has placed Vadilal Industries Limited's bank loan facilities on 'Rating Watch with Negative Implications'. The instruments affected include bank facilities previously rated IND A+ and IND A1+. While the company has low debt of Rs 78 Cr against net worth of Rs 579 Cr (D/E of 0.13), a Rating Watch with Negative Implications signals potential downgrade risks ahead. Investors should monitor subsequent rating agency updates to understand the specific triggers behind the negative watch.

India Ratings Upgrades Motilal Oswal Financial Services & Key Subsidiaries to 'IND AA+/Stable'

India Ratings and Research has upgraded the long-term credit rating of Motilal Oswal Financial Services Limited (MOFSL) and its key subsidiaries to 'IND AA+/Stable' from 'IND AA/Positive'. The upgrade covers NCDs and bank facilities across MOFSL, Motilal Oswal Home Finance, and Motilal Oswal Finvest, while group commercial paper ratings were affirmed at 'IND A1+'. Management highlighted that the group is now rated AA+ by all three leading domestic rating agencies, supported by net worth expanding to over ₹14,400 crore and recurring fee-based streams accounting for two-thirds of revenue.

India Ratings Upgrades Motilal Oswal Long-Term Rating to IND AA+/Stable

India Ratings & Research has upgraded Motilal Oswal Financial Services Limited's (MOFSL) long-term rating to 'IND AA+/Stable' from 'IND AA/Positive', while affirming its Commercial Paper rating at 'IND A1+'. The upgrade covers Rs 998.60 Cr in NCDs and Rs 400.00 Cr in bank loan facilities, alongside affirming Rs 11,750.00 Cr in Commercial Paper. The agency highlighted MOFSL's expanding business profile, rising recurring fee-based income (reaching 66% in 1QFY27), and growth in Assets Under Advice to Rs 7.9 trillion.

POSITIVE Impact 6/10 EXPANSION

Lalithaa Jewellery Opens 66th Store; Reports 26% YoY Q1 Revenue Growth and Margin Shift

Lalithaa Jewellery Mart has launched its 66th showroom in Mayiladuthurai, Tamil Nadu, covering 6,770 sq. ft., taking its store additions to 5 since April 2026. In its first management commentary post-listing, the company highlighted 26% YoY revenue growth for Q1 FY2027, reaching ₹6,031.23 cr. While inventory gain contributions dropped by over 90% YoY due to stable gold prices, core gross margin expanded by 20 bps YoY, driven by making charges revisions made in Q4 FY2026 and Q1 FY2027.

NEUTRAL Impact 5/10 EARNINGS

Lalithaa Jewellery Reports Q1 FY27 Revenue of ₹6,035 Cr, Down 7% QoQ; PAT at ₹208 Cr

Lalithaa Jewellery Mart has released its investor presentation detailing its Q1 FY27 financial performance and retail footprint. Total income reached ₹6,035 crore, marking a 26% YoY increase but a 7% QoQ decline compared to Q4 FY26. PAT dropped 22% YoY and 40% QoQ to ₹208 crore, with net margin narrowing to 3.5% from 5.5% in Q1 FY26. The company operates 65 stores across 55 cities in South India, generating 92% of revenue from gold jewellery.

NEUTRAL Impact 6/10 EARNINGS

Q1 FY27 Revenue at ₹6,039.56 Cr; Standalone PAT at ₹208.38 Cr

Lalithaa Jewellery Mart reported standalone revenue from operations of ₹6,039.56 crore (INR 60,395.57 million) for Q1 ended June 30, 2026, up 26.2% YoY compared to ₹4,786.15 crore in Q1 FY26. Standalone profit after tax stood at ₹208.38 crore (INR 2,083.81 million), down 21.1% YoY from ₹263.98 crore, impacted by higher cost of materials and purchases. Subsequent to the quarter, the company completed its IPO raising a fresh issue of ₹1,200 crore and listed on August 24, 2026. The board also approved an overseas investment of ₹17.12 crore (INR 171.15 million) into its Malaysian subsidiary.

WATCH Impact 8/10 OTHER

Vadilal Industries Faces Domestic Distribution Disruption as 10-Yr Agreement Renewal Fails

Vadilal Industries announced that its 10-year domestic sale and purchase agreement with Vadilal Enterprises Limited, set to expire on September 30, 2026, will not be renewed from October 1, 2026. While Vadilal Industries' public shareholders approved the renewal, Vadilal Enterprises failed to secure the required approval from its public shareholders. This agreement governs the principal domestic distribution channel for Vadilal Industries' ice cream, frozen desserts, and processed foods. The company generated ₹1,675 Cr in TTM revenue, making the prompt resolution of domestic distribution crucial for operational stability.

WATCH Impact 6/10 BOARD_MEETING

Goyal Aluminiums approves divestment in Wroley E India and ₹100 Cr related party transaction limit

Goyal Aluminiums has approved the divestment of its investment in associate company Wroley E India Private Limited, leading to its cessation as an associate. Additionally, the Board approved an aggregate limit for material related party transactions of up to ₹100 crores, which represents ~130% of its TTM revenue of ₹77 crores. The Board also approved the convening of its 10th Annual General Meeting and the FY26 Annual Report.

POSITIVE Impact 5/10 EXPANSION

Lalithaa Jewellery Launches 65th Showroom (6,918 Sq. Ft.) at Redhills, Chennai

Lalithaa Jewellery Mart Limited has announced the opening of its 65th showroom at Redhills, Chennai. The new store spans 6,918 sq. ft. and offers a comprehensive range of gold, diamond, and silver jewellery. This store addition is part of the company's ongoing retail network expansion in key southern markets.

NEUTRAL Impact 5/10 M&A

Dr. Lal PathLabs Completes Acquisition of 30% Stake in Neuome Technologies via Venture Arm

Dr. Lal PathLabs announced that its wholly-owned subsidiary, Dr. Lal Ventures Private Limited, completed the subscription of a 30% stake in Neuome Technologies Private Limited on August 27, 2026. Following the transaction, Neuome Technologies has become an associate of the company. The financial consideration for the investment was not disclosed in this filing, following an initial approval intimation on July 24, 2026.

NEUTRAL Impact 5/10 EARNINGS

Rs 48.99 Lakhs Profit from Associate Highlighted in Goyal Aluminiums Q1 FY27 Results

Goyal Aluminiums Limited has reported its financial results for the quarter ended June 30, 2026. The consolidated results feature a profit contribution of Rs 48.99 lakhs from its associate, Wroley E India Private Limited. This associate remains a critical component of the company's bottom line, following a Rs 1.23 Cr contribution in FY26. The auditors issued a clean review report, though they noted the associate's results were management-certified and not independently reviewed by them.

1 2 … … 5 6 Next →
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI